HHBT | HH Biotechnology Holdings Company Annual &

Annual Cash Flows

(In USD)

Breakdown	2015
Operating Cash Flow	3.57 Million
Net Income	2.47 Million
Depreciation & Amortization	-3.21 Million
Deferred income taxes	-
Stock-based compensation	-
Change in working capital	162.03 Thousand
Other non-cash items	-2.23 Million
Investing Cash Flow	-41.9 Thousand
Investments in PPE	-41.9 Thousand
Acquisitions	-
Investment purchases	-
Sales/Maturities of investments	-
Other Investing Activities	-
Financing Cash Flow	-2.46 Million
Debt repayment	-16.22 Million
Dividends payments	-
Common Stock Repurchased	-
Common Stock Issuance	7.54 Million
Other Financing Activities	6.21 Million
Accounts receivables	-223.64 Thousand
Accounts payables	176.82 Thousand
Inventory	-
Other working capital	208.86 Thousand
Cash at beginning of period	-
Cash at end of period	1.06 Million
Capital Expenditure	-41.9 Thousand
Effect of forex changes on cash	-
Net cash flow / Change in cash	1.06 Million
Free Cash Flow	3.53 Million

Breakdown	2015 FY
Operating Cash Flow	-
Net Income	2.47 Million
Depreciation & Amortization	-3.21 Million
Deferred income taxes	-
Stock-based compensation	-
Change in working capital	162.03 Thousand
Other non-cash items	-2.23 Million
Investing Cash Flow	-41.9 Thousand
Investments in PPE	-41.9 Thousand
Acquisitions	-
Investment purchases	-
Sales/Maturities of investments	-
Other Investing Activities	-
Financing Cash Flow	-2.46 Million
Debt repayment	-16.22 Million
Dividends payments	-
Common Stock Repurchased	-
Common Stock Issuance	7.54 Million
Other Financing Activities	6.21 Million
Accounts receivables	-223.64 Thousand
Accounts payables	176.82 Thousand
Inventory	-
Other working capital	208.86 Thousand
Cash at beginning of period	-
Cash at end of period	1.06 Million
Capital Expenditure	-41.9 Thousand
Effect of forex changes on cash	-
Net cash flow / Change in cash	1.06 Million
Free Cash Flow	3.53 Million